SPOTLIGHT -
Strangers to Ourselves: Unsettled Minds and the Stories That Make Us
“Rachel Aviv speaks to the stories that help and stories that harm—the narratives that will fashion the identity we will have for a lifetime.”
Interviewing Groundhog Phil and the Tu BiShvat Tree
Imagine an interview with these 2 talking entities…
The Week in Review: January 30-February 3
From addressing physician burnout to helping your patients incorporate friendships into their lives, here are highlights from the week in Psychiatric Times.
Psychiatry Comic: Scarecrow
Seems like a reasonable assessment...
Celebrating Black Joy
“Maybe Black History Month should be more centered around the contributions of Black Americans—what they have contributed to what this country is. I would love to know more about that.”
"Anatomy Lab"
"By year’s end, brittle with guilt, we hovered over our hollow creation..."
Psychiatric Lessons from the Memphis Scorpions: What’s in a Name?
Names can hurt, and they can lead to broken bones.
Psychiatric Lessons from the Memphis Scorpions: The Intergenerational Transmission of Trauma
Could police brutality be part of a larger legacy of American trauma transmission?
Taking Psychoanalysis off the Couch and Into the World: 2022 Sigourney Award Winner
The 2022 Sigourney Award winner reflects on her work.
Burning Out About Physician Burnout
“Anyone who cares about patients is doomed to burnout.”
Celebrating Black History Month 2023
In honor of Black History Month, Psychiatric Times™ highlights the contributions of Black clinicians to the field of psychiatry, as well as issues that continue to impact this underrepresented community.
From the Pages of Psychiatric Times: January 2023
The experts weighed in on a wide variety of psychiatric issues for the January 2023 issue of Psychiatric Times.
Shelter in Place
“Bringing us home, To ourselves, Our selves, Our bodies, our shelters…”
Psychiatric Lessons from the Memphis Scorpions: The Importance of Supervision in the Helping Professions
Should we try to be the keepers of our brothers and sisters?
There is a World of Social Psychiatric Challenges and You can Help Solve Them!
How can you get involved and be more knowledgeable about social psychiatry?
A Blues for Tyre
A psychiatric reflects on the latest news and remembers Tyre Nichols.
The Week in Review: January 23-27
From special issues in diagnosing and treating catatonia to helping justice-involved individuals re-enter the community, here are highlights from the week in Psychiatric Times.
Psychiatry Comic: Guilt Complex
No good deed goes unpunished...
FDA Announces Need for New Regulatory Pathway for CBD
The agency’s conclusions are based on regulatory oversight needed to manage risks associated with CBD and other cannabis-derived products.
Watching for Words as Weapons on International Holocaust Remembrance Day
Be on the lookout for anti-Semitic messages.
Doomsdays and the Eulogies of These Psychiatrists
In remembrance of those we lost…
Positive Results from Phase 2a Trial of Psychedelic for Major Depressive Disorder
SPL026 with supportive therapy sees positive results in patients with major depressive disorder.
Connection, Hope, Purpose, and Empowerment for Justice-Involved Individuals Reentering the Community
How can recovery-oriented cognitive therapy be a game changer for these individuals?
Grief
“We are oceans, not boats.”
Will This Be the Year of More Return to Our Technological Past?
Back to the future… or blast to the past?
Recovery-Oriented Cognitive Therapy: Changing Lives With a Whole-Person Approach
Are you ready to understand how recovery-oriented cognitive therapy (CT-R) promotes wellness and empowerment for individuals experiencing serious mental health challenges? Check out this CME article.
The Many Faces of Catatonia, An Under-Recognized Clinical Syndrome
Catatonia: learn more about how to best diagnose early.
A Lapse of Cultural Psychiatrist Humility in the Monterey Mass Shooting
This morning, we mourn the victims of the Monterey Park mass shooting.
The Week in Review: January 16-20
From a new FDA approval to treating “New Year depression” in patients, here are highlights from the week in Psychiatric Times.
NDA Accepted for Nasal Nalmefene for Opioid Overdose
The FDA has accepted the NDA for nasal nalmefene, OPNT003, to treat opioid overdose.
